Lost in the wilderness
There are certain fundamental truths when it comes to our wacky world. One is pharmaceutical companies have no business getting into MedTech or digital/virtual. Yesterday we wrote about the posterchild for screwing up Sanofi. Yep, instead of getting out of diabetes and selling the franchise when it has value, they invest $30 million in Dario. Honestly, I truly wish Dexcom would make them an offer they can’t refuse and be done with it but then again Sanofi just doesn’t have the capacity to recognize a good deal.
Sanofi isn’t the only company in pharma who has . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.